# RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

> **NCT03624192** · NA · TERMINATED · sponsor: **Avita Medical** · enrollment: 3 (actual)

## Conditions studied

- Skin; Deformity

## Interventions

- **DEVICE:** RECELL® Autologous Cell Harvesting Device
- **OTHER:** Telfa™ Clear and Xeroform™ dressings

## Key facts

- **NCT ID:** NCT03624192
- **Lead sponsor:** Avita Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-19
- **Primary completion:** 2020-01-13
- **Final completion:** 2020-01-13
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study closed in response to COVID-19 and overall program objectives.
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03624192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03624192, "RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03624192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*